Adenovir Pharma is a Swedish based development company developing new solutions for treatment of certain infectious diseases affecting the eyes. Adenovir Pharma was founded by researchers at the department of Virology, Umeå University, Sweden and the P.U.L.S. AB network.
The development is conducted at the Universities of Lund and at the University of Umeå, Sweden and in collaboration with the P.U.L.S. network and external service providers. With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry.
CEO Björn Dellgren
Contact details
Kullagatan 8 , SE-252 20Helsingborg, Sweden
Phone: +46 42 38 74 28
bjorn.dellgren@adenovir.com
